Amarantus Bioscience Holdings Inc. (OTCMKTS:AMBS – Get Free Report) saw a significant growth in short interest in the month of October. As of October 15th, there was short interest totaling 73,532 shares. Based on an average daily volume of 37,191 shares, the days-to-cover ratio is currently 2.0 days.
Amarantus Bioscience Stock Performance
Amarantus Bioscience has a 1 year low of $0.00 and a 1 year high of $0.01.
Amarantus Bioscience Company Profile
Amarantus Bioscience, Inc is a biotechnology company that historically focused on developing therapeutics and diagnostics for neurological and other serious diseases. Its research programs centered on mesencephalic astrocyte-derived neurotrophic factor (MANF), a naturally occurring protein investigated for potential applications in disorders involving nerve-cell damage.
The company also pursued the development of NuroPro, a blood-based diagnostic platform intended to identify biomarkers associated with neurodegenerative diseases, including Parkinson’s disease.
Read More
- Five stocks we like better than Amarantus Bioscience
- Starbucks Says Its Turnaround Is Done—The Numbers Make a Strong Case (With 1 Catch)
- 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
- Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom
Receive News & Ratings for Amarantus Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amarantus Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
